Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Molecular Features of Diffuse Large B‐Cell Lymphoma Associated With Primary Treatment Resistance

Hematological Oncology(2024)10.1002/hon.70006Source: DataRank Database

Molecular Features of Diffuse Large B‐Cell Lymphoma Associated With Primary Treatment Resistance is a research paper published in Hematological Oncology (2024). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.91)OA: hybridTopics (38)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (22)

Kerstin Wenzl ORCID,Joseph P. Novak ORCID,Matthew E. Stokes ORCID,Melissa A. Hopper ORCID,Jordan E. Krull ORCID

Live enrichment

PubMed:39612356 PMC:PMC11606593 OpenAlex:https://openalex.org/W4404840903

NCI NIH HHS

Grant: P30 CA015083

NIAID NIH HHS

Grant: T32 AI170478

National Institutes of Health

Tanoto Foundation

Predolin Foundation Biobank

NIH HHS

FWCI

0.91

Citation Percentile

0.8%

Citation Trend

2026

hybridLicense: cc-by-nc-nd

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hon.70006

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hon.70006

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.70006

journalhttps://doi.org/10.1002/hon.70006

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39612356

Fields of Study

Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia ResearchCancer-related gene regulation

MeSH Terms

AdultAgedAged, 80 and overDNA-Binding ProteinsFemaleHumansMaleMiddle AgedMutationPrognosisTranscription FactorsBiomarkers, TumorTumor Suppressor Protein p53Lymphoma, Large B-Cell, DiffuseDrug Resistance, Neoplasm

Keywords

ARID1ADiffuse large B-cell lymphomaExome sequencingOncologyCancer researchLymphomaExomeInternal medicineMedicineChromatinBiologyGeneComputational biologyBioinformaticsGeneticsMutationGenomicsPrimary Refractory DlbclLarge B‐Cell LymphomaPrimary Treatment Resistance

Sustainable Development Goals

SDG 0: Good health and well-being

Molecular Features of Diffuse Large B‐Cell Lymphoma Associated With Primary Treatment Resistance

FAIR Checklist

Authors (22)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)